Wasting syndrome: oral oxandrolone re-released in U.S.
James
J S
JS
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000284:Administration, Oral; D002100:Cachexia / Q000150:complications / Q000188:drug therapy*; D017277:Drug Approval; D016527:Drug Costs; D006801:Humans; D010074:Oxandrolone / Q000008:administration & dosage / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D010074:Oxandrolone